146 related articles for article (PubMed ID: 7070237)
1. [Dose, time and volume factors in interstitial therapy of tongue neoplasms with cf-252].
Vtiurin BM; Ivanov VN; Abdulkadyrov SA; Ivanova LF
Med Radiol (Mosk); 1982 Feb; 27(2):3-8. PubMed ID: 7070237
[No Abstract] [Full Text] [Related]
2. [Radiation ulcers after Cf-252 treatment of patients with cancer of the tongue].
Galantseva GF; Guseva LI; Plichko VI
Med Radiol (Mosk); 1984 Jan; 29(1):57-62. PubMed ID: 6694546
[TBL] [Abstract][Full Text] [Related]
3. [Interstitial neutron therapy using flexible 252Cf sources].
Vtiurin BM; Medvedev VS; Ivanov VN; Elisiutin GP; Petrovskaia GA
Med Radiol (Mosk); 1984 Jun; 29(6):7-16. PubMed ID: 6738328
[TBL] [Abstract][Full Text] [Related]
4. [Immediate and early results with the contact irradiation of tumors using 252Cf sources].
Vtiurin BM; Galantseva GF; Medvedev VS; Abdulkadyrov SA
Radiobiol Radiother (Berl); 1983; 24(2):157-63. PubMed ID: 6867298
[No Abstract] [Full Text] [Related]
5. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue.
Inoue T; Inoue T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():291-5. PubMed ID: 10895169
[No Abstract] [Full Text] [Related]
6. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue.
Inoue T; Inoue T; Yoshioka Y; Yoshida K
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():296-300. PubMed ID: 10895170
[No Abstract] [Full Text] [Related]
7. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of a radiolucent spacer in radiation therapy for cancer of the tongue].
Niwa K; Morita K; Kanazawa H; Yokoi M
Gan No Rinsho; 1984 Dec; 30(15):1861-5. PubMed ID: 6441853
[TBL] [Abstract][Full Text] [Related]
9. [Concept of the nominal standard dosage as applied to the intracavitary therapy of oncological gynecologic patients using 60Co and 252Cf].
Nikishin BK; Gaponenko ED; Koval' GN; Abdullaev VD
Med Radiol (Mosk); 1979 Dec; 24(12):53-7. PubMed ID: 514002
[No Abstract] [Full Text] [Related]
10. High dose rate interstitial brachytherapy for mobile tongue cancer: Part 1. Phase I/II study of HDR hyperfractionated interstitial brachytherapy for oral cancer.
Inoue T; Inoue T; Teshima T
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():287-90. PubMed ID: 10895168
[No Abstract] [Full Text] [Related]
11. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma.
Guinot JL; Santos M; Tortajada MI; Carrascosa M; Estellés E; Vendrell JB; Muelas R; Chust ML; Mengual JL; Arribas L
Brachytherapy; 2010; 9(3):227-34. PubMed ID: 20116340
[TBL] [Abstract][Full Text] [Related]
12. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.
Maruyama Y; Mesina J; Yudelev M; Wierzbicki J; Deppe G; Porter AT
Strahlenther Onkol; 1994 May; 170(5):253-63. PubMed ID: 8197547
[TBL] [Abstract][Full Text] [Related]
13. [ORL brachytherapy. Brachytherapy of epidermoid carcinoma of the oral cavity].
Haie-Meder C; Marsiglia H; Mamelle G; Wibault P; Lartigau E; Gerbaulet A
Bull Cancer Radiother; 1995; 82(2):186-90. PubMed ID: 7546889
[No Abstract] [Full Text] [Related]
14. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma.
Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G
Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696
[TBL] [Abstract][Full Text] [Related]
15. Schedule in Cf-252 neutron brachytherapy: complications after delayed implant therapy for cervical cancer in a phase II trial.
Maruyama Y; van Nagell JR; Yoneda J; Gallion HH; DePriest P; Feola JM; Wierzbicki J
Am J Clin Oncol; 1993 Apr; 16(2):168-74. PubMed ID: 8452113
[TBL] [Abstract][Full Text] [Related]
16. [The interstitial radiation therapy of cancer of the tongue and mucosa of the floor of the mouth].
Zamiatin OA; Vakhramova MP; Razorenova EV
Vopr Onkol; 1995; 41(2):112-4. PubMed ID: 7483404
[No Abstract] [Full Text] [Related]
17. [Clinical dosimetry in radium 226 and iridium 192 interstitial therapy of oral tongue cancer (author's transl)].
Baroncelli G; Feroldi P; Frata P
Radiol Med; 1980 Nov; 66(11):819-26. PubMed ID: 7221048
[TBL] [Abstract][Full Text] [Related]
18. [Combined neutron and gamma-therapy of tongue cancer].
Vtiurin BM; Ivanov VK; Ivanov VN; Medvedev VS; Abdulkadyrov SA
Med Radiol (Mosk); 1986 Sep; 31(9):14-9. PubMed ID: 3762346
[TBL] [Abstract][Full Text] [Related]
19. [Clinical experience with high dose rate afterloading interstitial radiation--a preliminary report].
Itami J; Saegusa K; Okada J; Fujimoto H; Miyagawa K; Uno K; Miyoshi T; Arimizu N; Mamiya T
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):80-6. PubMed ID: 3084688
[No Abstract] [Full Text] [Related]
20. [Principles of dosimetric planning in contact therapy with highly active Cf-252 sources].
Chekhonadskij VN; Merkle K
Strahlenther Onkol; 1987 Nov; 163(11):742-5. PubMed ID: 3686338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
